| Do mean platelet volume and platelet count vary on a daily or gender basis? Ö Candar, Ö Ekinci, A Doğan, S Ebinç Journal of Current Hematology & Oncology Research 2 (1), 6-9, 2024 | | 2024 |
| Evaluation of the frequency of hepatitis b virus reactivation and the importance of hepatitis b prophylaxis in hematology patients receiving immunosuppressive therapy: a single … A Doğan, Ö Ekinci, N Yıldırım Doğan, T Kıvanç, S Demircioğlu, C Demir, ... Journal of Current Hematology & Oncology Research 1 (4), 83-87, 2023 | | 2023 |
| A CASE OF DAPSONE-INDUCED HEMOLYTİC ANEMİA RELATED TO G6PD ENZYME DEFİCİENCY A Dogan, O Ekıncı, NY Dogan, S Demırcıoglu, C Demır, C Ural, R Esen Hematology, Transfusion and Cell Therapy 45, S41-S42, 2023 | | 2023 |
| Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey M Bakırtaş, MS Dal, TN Yiğenoğlu, AO Giden, I Serin, S Başcı, Y Kalpakci, ... Journal of Chemotherapy 35 (6), 563-569, 2023 | 2 | 2023 |
| International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report D Ozatli, AO Giden, MA Erkurt, S Korkmaz, S Basci, T Ulas, B Turgut, ... Transfusion and Apheresis Science 62 (2), 103662, 2023 | | 2023 |
| Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study R Acar, S Paydaş, M Yıldırım, E Kılıçarslan, U Sahın, A Dogan, DC Guven, ... Journal of Cancer Research and Therapeutics 19 (Suppl 1), S138-S144, 2023 | | 2023 |
| A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera İ Serin, M DOĞU, O EKINCI, G ÇAĞLIYAN, A BAŞTÜRK, M ARAS, ... İstanbul Medical Journal 24 (2), 2023 | | 2023 |
| CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study U Demirci, HO Kırkızlar, EG Ümit, V Gürsoy, İE Pınar, F Özkalemkaş, ... Journal of Hematopathology 15 (4), 203-213, 2022 | 1 | 2022 |
| Akut Miyeloid Lösemili Hastalarda Akış Sitometrik İmmünofenotiplemenin Prognostik Önemi S DEMİRCİOĞLU, Ö EKİNCİ, A DOĞAN, T ULAŞ Bezmialem Science, 2022 | | 2022 |
| PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA A Basturk, M Bagci, MS Dal, T Hacibekiroglu, SK Hacioglu, I Aydogdu, ... HemaSphere 6, 1943-1944, 2022 | | 2022 |
| Castleman disease: a multicenter case series from Turkey E Gündüz, HO Kırkızlar, EG Ümit, SK Gülsaran, V Özkocaman, ... Turkish Journal of Hematology 39 (2), 130, 2022 | | 2022 |
| The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL S Akpinar, MH Dogu, S Celik, O Ekinci, IY Hindilerden, MS Dal, ... Clinical Lymphoma Myeloma and Leukemia 22 (3), 169-173, 2022 | 5 | 2022 |
| The clinicopathological features and survival of Castleman disease: a multicenter Turkish study. J Yildiz, M Bagci, S Sayin, A Kaya, F Yilmaz, O Ekinci, MS Dal, A Basturk, ... European Review for Medical & Pharmacological Sciences 26 (4), 2022 | 3 | 2022 |
| Results of multicenter registry for patients with inherited factor VII deficiency in Turkey A Akdeniz, A Ünüvar, MC Ar, E Pekpak, A Akyay, Ö Mehtap, FK Karadağ, ... Scandinavian journal of clinical and laboratory investigation 82 (1), 28-36, 2022 | 2 | 2022 |
| Castleman Disease: A Multicenter Case Series from Turkey E Gunduz, HO Kirkizlar, EG Umit, SK Gulsaran, V Ozkocaman, ... TURKISH JOURNAL OF HEMATOLOGY 39 (2), 130-135, 2022 | | 2022 |
| The Real-World Experience With Single Agent Ibrutinib in S Akpinar, MH Dogu, S Celik, O Ekinci, IY Hindilerden, MS Dal, ... | | 2022 |
| The clinicopathological features and survival of Castleman disease: a J Yildiz, M Bagci, S Sayin, A Kaya, F Yilmaz, O Ekinci, MS Dal, A Basturk, ... | | 2022 |
| Castleman Disease: A Multicenter Case Series from Turkey Castleman Hastalığı: Türkiye’den Çok Merkezli Bir Olgu Serisi E GÜNDÜZ, H Kırkızlar, E ÜMİT, S Gülsaran, V ÖZKOCAMAN, ... Turkish Journal of Hematology 39 (2), 2022 | | 2022 |
| Impact of COVID-19 on outcomes of patients with hematologic malignancies: A multicenter, retrospective study IH Acar, SI Guner, MA Ak, M Gocer, E Ozturk, F Atalay, G Sincan, ... Mediterranean Journal of Hematology and Infectious Diseases 14 (1), 2022 | 2 | 2022 |
| Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia S Demircioglu, O Ekinci, A Doğan, T Ulas Bezmialem Science 10 (4), 2022 | | 2022 |
Ali DoganYüzüncü Yıl Üniversitesi在 yyu.edu.tr 的电子邮件经过验证
